Chemours Stock Price, Forecast & Analysis (NYSE:CC)

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Chemours declared a quarterly dividend on Wednesday, October 30th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.25 per share on Monday, December 16th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 4.99%. The ex-dividend date of this dividend is Thursday, November 14th. View Chemours' Dividend History.

Chemours declared that its Board of Directors has authorized a share repurchase program on Monday, December 4th 2017, which authorizes the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company's board believes its stock is undervalued.

Chemours Co (NYSE:CC) issued its quarterly earnings results on Monday, November, 4th. The specialty chemicals company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.56 by $0.03. The specialty chemicals company earned $1.39 billion during the quarter, compared to analysts' expectations of $1.40 billion. Chemours had a net margin of 7.24% and a return on equity of 58.38%. The company's revenue was down 14.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.49 EPS. View Chemours' Earnings History.

Chemours is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Chemours.

Chemours updated its FY19 earnings guidance on Monday, November, 4th. The company provided EPS guidance of $2.37-3.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.47.

13 brokerages have issued 1 year price targets for Chemours' stock. Their forecasts range from $14.50 to $52.00. On average, they expect Chemours' stock price to reach $27.14 in the next twelve months. This suggests a possible upside of 35.3% from the stock's current price. View Analyst Price Targets for Chemours.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Chemours.

News stories about CC stock have been trending very negative on Wednesday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemours earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news headlines about the specialty chemicals company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Chemours.

Chemours saw a increase in short interest in October. As of October 31st, there was short interest totalling 13,710,000 shares, an increase of 9.2% from the September 30th total of 12,560,000 shares. Based on an average daily trading volume, of 3,460,000 shares, the short-interest ratio is currently 4.0 days. Currently, 8.5% of the shares of the company are short sold. View Chemours' Current Options Chain.

Some companies that are related to Chemours include FMC (FMC), Johnson Matthey (JMPLY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), KURARAY CO LTD/ADR (KURRY), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), Olin (OLN), Innospec (IOSP), PQ Group (PQG), GCP Applied Technologies (GCP), Livent (LTHM) and Innophos (IPHS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), Micron Technology (MU), NVIDIA (NVDA), DowDuPont (DWDP), Alibaba Group (BABA), AT&T (T), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Intel (INTC) and Pfizer (PFE).

Chemours' stock is owned by a variety of of institutional and retail investors. Top institutional investors include DNB Asset Management AS (0.39%), Retirement Systems of Alabama (0.36%), Selz Capital LLC (0.34%), Alberta Investment Management Corp (0.30%), Rhumbline Advisers (0.26%) and California Public Employees Retirement System (0.21%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.

CC stock was sold by a variety of institutional investors in the last quarter, including Teacher Retirement System of Texas, Gateway Investment Advisers LLC, Selz Capital LLC, Great West Life Assurance Co. Can, Zurcher Kantonalbank Zurich Cantonalbank, Nisa Investment Advisors LLC, Brookstone Capital Management and Dupont Capital Management Corp. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.

CC stock was bought by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Traynor Capital Management Inc., WBI Investments Inc., State of New Jersey Common Pension Fund D, DNB Asset Management AS, Railway Pension Investments Ltd, Investors Research Corp and Pacer Advisors Inc.. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CC stock can currently be purchased for approximately $20.05.

Chemours has a market capitalization of $3.28 billion and generates $6.64 billion in revenue each year. The specialty chemicals company earns $995 million in net income (profit) each year or $5.67 on an earnings per share basis. Chemours employs 7,000 workers across the globe.View Additional Information About Chemours.

The official website for Chemours is http://www.chemours.com/.

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]